Otitis Media AcuteNCT07246551
Gamified Training and AI Support for Improving Ear Infection Diagnosis in Primary Care
A study testing AOM Dx Trainer (gamified educational program) in people with Otitis Media Acute and Otitis Media Effusion, run by Vastra Gotaland Region.
Trial summary
Acute otitis media (AOM), or middle ear infection, is one of the most common childhood infections and a leading cause of antibiotic prescribing in primary care. Diagnosing AOM can be challenging, as ear symptoms and eardrum appearances often overlap with mild or transient conditions. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Otitis Media Acute, Otitis Media Effusion
- What is being tested?
- AOM Dx Trainer (gamified educational program)
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- No sites listed yet
- Study dates
- 1 Dec 2025to 31 Dec 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Newly developed ear discomfort or symptoms within the past month. The patient seeks care at a participating primary care centre and is assessed by a physician because of these ear-related symptoms. Alternatively, for young children: respiratory tract infection with concurrent signs or symptoms suggesting possible ear involvement, even if the child cannot clearly express ear pain.
- Age: Children and adults of all ages are eligible to participate.
- Informed consent: The patient (or guardian for minors) agrees to participate and provides written informed consent. For children under 15 years, consent is obtained from both guardians before any data storage.
- The patient must have been managed by a physician who has consented to participate in the study (as a physician participant) and who is a GP specialist, GP resident, or junior physician (intern or basic training physician) working at the primary care centre.
- At intervention centres, the managing physician must have completed the AOM Diagnosis (Dx) Trainer and reached the required score threshold ("diploma") before including patients.
- General practitioners (GP specialists), GP residents, or junior physicians (interns or basic training physicians) working clinically at participating primary care centres.
Show all 9Show fewer
- Have provided written informed consent to participate in the study as physician participants.
- At intervention centres, must have completed the AOM Dx Trainer and achieved the required diploma level before patient inclusion.
- At control centres, receive no access to the AOM Dx Trainer during the study period.
Who cannot join
- Withdrawal of consent by the participant (physician or patient).
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Enhancing Diagnosis of Otitis Media in Primary Care: Gamified Training and AI-Driven Tools
Acute otitis media (AOM), or middle ear infection, is one of the most common childhood infections and a leading cause of antibiotic prescribing in primary care. Diagnosing AOM can be challenging, as ear symptoms and eardrum appearances often overlap with mild or transient conditions. This uncertainty may lead to both unnecessary antibiotic use and missed cases requiring treatment, affecting patient safety and contributing to antibiotic resistance.
This study evaluates two digital tools designed to support more accurate diagnosis and treatment decisions in primary care:
Read more
- AOM Dx [diagnosis] Trainer (Otitspelet) - a gamified digital training program for physicians that provides interactive exercises using eardrum images and patient cases, with direct feedback to improve diagnostic accuracy and adherence to guidelines.
- AI-based diagnostic support - a system that analyses tympanic membrane images, with and without symptom and tympanometry data, to evaluate its potential for future diagnostic use.
The trial is coordinated by the Västra Götaland Region (VGR) in collaboration with Umeå University and conducted across four Swedish regions: Västra Götaland, Västerbotten, Östergötland, and Skåne. VGR leads the evaluation of the AOM Dx Trainer intervention, while Umeå University leads the AI development and retrospective diagnostic analyses. The study is carried out as a multicentre, cluster-randomised controlled trial in primary care, where participating primary care centres are randomised to either the training intervention or standard care.
Physicians are the research participants under evaluation. At intervention centres, physicians complete training with the AOM Diagnosis (Dx) Trainer before study start; at control centres, no training is provided. Each participating centre then conducts an 8-week observation period, during which physicians diagnose and manage patients with new-onset ear symptoms. Patients are included only to allow evaluation of physicians' diagnostic and treatment decisions and to provide data for AI analysis. Estimated patient enrollment is ~200. Depending on centre size and recruitment success, up to 20 primary care centres across four Swedish regions - Västra Götaland, Västerbotten, Östergötland, and Skåne - will participate. After each consultation, research nurses collect tympanic membrane images and tympanometry data from patients who have given informed consent. These data are used for expert panel reference diagnoses and retrospective AI analysis; no information is shared with treating physicians.
The primary outcome is diagnostic accuracy of tympanic membrane assessment by physicians trained with the AOM Dx Trainer compared with untrained physicians, using expert consensus as the reference standard. Secondary outcomes include adherence to treatment guidelines and antibiotic prescribing rates. The AI system's diagnostic performance will also be benchmarked against the expert panel and physician groups.
By combining educational and technological innovation, this study aims to enhance diagnostic precision, improve guideline adherence, and reduce unnecessary antibiotic use in primary care-strengthening antimicrobial stewardship and providing a scalable model for future infection management.
Read the detailed description
This multicentre, cluster-randomised controlled trial evaluates two digital innovations for improving diagnostic accuracy and treatment quality in acute otitis media (AOM) management in Swedish primary care: a gamified training tool for physicians (AOM Diagnosis [Dx] Trainer) and an AI-based diagnostic support system. The study assesses diagnostic accuracy, adherence to evidence-based treatment guidelines, and comparative AI performance.
The trial is coordinated by the Västra Götaland Region (VGR) in collaboration with Umeå University and conducted across four Swedish regions: Västra Götaland, Västerbotten, Östergötland, and Skåne. Up to 20 primary care centres will participate, depending on centre size and recruitment rates. Centres are randomised to either the AOM Dx Trainer intervention or standard care (control).
Study design and participants:
Both physicians and patients are research participants. Physicians in the intervention arm complete the AOM Dx Trainer before patient inclusion begins, while control physicians receive no training. Each centre recruits consecutive patients with new-onset ear symptoms (≤1 month) during an 8-week inclusion period (intervention or control). Consultations are conducted according to standard clinical practice. After each visit, research nurses ensure eligibility and consent and collect tympanic membrane images and tympanometry data solely for research purposes.
Interventions:
The AOM Dx Trainer is a gamified, case-based training tool designed to improve recognition of AOM and related conditions. Physicians classify anonymised tympanic images with symptom vignettes into diagnostic categories and receive immediate feedback. Training continues until a predefined performance threshold is reached.
The AI diagnostic tool, developed at Umeå University, uses convolutional neural networks (CNNs) to analyse tympanic images, with or without symptom and tympanometry data. AI analyses will be performed retrospectively in a laboratory setting and will not influence patient care.
Data collection:
After each visit, patients meet a research nurse who ensures eligibility and consent, and records demographics, symptom severity (AOM-SOS v5), and potential complicating factors (e.g., severe pain despite analgesics, immunosuppression, previous ear surgery, cochlear implant). The physician's diagnosis and any antibiotic prescription (drug and duration) are documented for later comparison with guideline recommendations and expert panel consensus. Physician characteristics are recorded under pseudonymised IDs. Tympanic membrane images are captured using CE-marked video otoscopes (EarPenguin) and tympanometry devices. All data are entered into case report forms (CRFs) and stored securely but are not shared with treating physicians, ensuring real-world diagnostic conditions.
Data handling and ethics:
All data are pseudonymised. Code keys are securely stored within each region. The national coordinating centre in Gothenburg oversees data management and quality assurance. Data are stored on GDPR-compliant servers. Ethical approval has been granted by the Swedish Ethical Review Authority (Ref. 2025-03523-01).
Expert panel reference diagnoses:
Tympanic images and tympanometry results are reviewed retrospectively by an expert panel (two ENT specialists and one senior GP). Consensus diagnoses serve as the reference standard for assessing diagnostic accuracy among physicians and for benchmarking AI performance.
Primary outcome:
Diagnostic accuracy of tympanic membrane classification (normal, AOM, erythematous membrane without effusion, or otitis media with effusion) compared with expert consensus.
Secondary outcomes:
Adherence to national treatment guidelines; antibiotic prescribing rates and duration; and comparative diagnostic performance between physicians and AI configurations.
Sample size and power:
The sample size calculation targets the primary research question. Using a bivariate logistic regression as a proxy (outcome: correct vs. incorrect diagnosis; predictor: intervention status), unpublished data from our group suggest approximately 50% diagnostic accuracy among physicians without AOM Dx Trainer training. We hypothesize an improvement to around 75% among trained physicians, which is considered a clinically relevant threshold. Assuming a two-sided alpha of 0.05 and 95% power, a minimum of 195 patients is required (G*Power 3.1.9.7). Therefore, approximately 200 patients will be recruited, with roughly equal numbers in the intervention and control arms. This target aligns with the planned multicentre cluster-randomised design and is feasible within the established Swedish primary care research network.
- Conditions
- Otitis Media Acute, Otitis Media Effusion
- Being tested
- AOM Dx Trainer (gamified educational program), No Intervention - Standard Care
- Keywords
- Otitis Media, Primary Health Care, Artificial Intelligence, Antimicrobial Stewardship, Clinical Decision Support Systems
- Medical subject headings
- Otitis Media, Otitis Media with Effusion
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AOM Dx Trainer (gamified educational program)Behavioural
Educational digital training program for physicians, not psychotherapy or counseling. Designed to improve diagnostic accuracy in acute otitis media through gamified learning with feedback.
No Intervention - Standard CareOther
Participants in this arm will receive standard care according to clinical routines, without access to the AOM Diagnosis (Dx) Trainer. No experimental or additional interventions will be applied.
| Study group | Role | What they receive |
|---|---|---|
| No Intervention: Standard Care - Control Group | Active comparator | Physicians at control centres will provide standard care without access to the AOM Dx Trainer. Consultations will proceed as usual for patients with ear symptoms. Research nurses will collect tympanic membrane images and tympanometry data for expert panel and AI evaluation. Receives: Other: No Intervention - Standard Care |
| Behavioral: AOM Dx Trainer - Intervention Group | Experimental | Primary care physicians at centres randomized to the intervention arm will complete training with the AOM Diagnosis (Dx) Trainer, a gamified educational program designed to improve diagnostic accuracy in acute otitis media. After completing the training, these physicians will manage patients as usual. Research nurses will collect tympanic membrane images and tympanometry data for expert panel and AI evaluation. Receives: Behavioral: AOM Dx Trainer (gamified educational program) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Diagnostic accuracy of tympanic membrane assessment by primary care physicians
Diagnostic accuracy of tympanic membrane classification (normal, acute otitis media, erythematous membrane without effusion, or otitis media with effusion) by primary care physicians trained with the AOM Dx Trainer compared with untrained physicians (control group).
Accuracy is defined as correct versus incorrect diagnosis relative to the expert panel consensus.
Analysed using mixed-effects logistic regression adjusted for physician sex, age, and training level (GP specialist, resident, or junior physician), with physician ID included as a random effect to account for clustering at the physician level.
Measured: During the 8-week inclusion period at each participating centre (per patient consultation).
Secondary outcomes (2)
Adherence to national AOM treatment guidelines
Proportion of correct vs. incorrect treatment decisions (antibiotic vs. watchful waiting, drug choice, duration) according to national guidelines, comparing trained vs. untrained physicians.
Analysed using mixed-effects logistic regression with the same covariates and random effect as for the primary outcome.
Measured: During the 8-week inclusion period at each participating centre (per patient consultation).
Diagnostic performance across groups
Sensitivity, specificity, predictive values, and ROC analyses (with 95% confidence intervals) will be calculated for classification of the four tympanic membrane categories. Performance will be compared against the expert panel, separately for:
- physicians without training,
- physicians with AOM Dx Trainer training,
- the AI diagnostic tool, evaluated with (i) image only, (ii) image + symptoms, (iii) image + tympanometry, and (iv) all modalities combined.
In this project, the AI will be evaluated retrospectively in a laboratory setting and will not influence clinical consultations; all patient care remains the responsibility of the treating physician.
Measured: Retrospective analysis after completion of data collection (expected within 12 months of final patient inclusion).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Nov 2025
- Study start1 Dec 2025 (estimated)
- Primary completion1 Dec 2027 (estimated)
- Study completion31 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Otitis Media AcuteStudies of the same condition, open and under way.
- More trials run by Vastra Gotaland RegionThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Vastra Gotaland Region
- Sponsor type
- Other government
- Collaborators
- Umeå University, Lund University, Linkoeping University, Göteborg University
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07246551
- Sponsor's protocol ID
- 2025-03523-01
- Other IDs
- 2025
- Status last verified
- Oct 2025
- First submitted
- 17 Nov 2025
- Last updated
- 24 Nov 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Nov 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Enhancing Diagnosis of Otitis Media in Primary Care: Gamified Training and AI-Driven Tools
- ClinicalTrials.gov ID
- NCT07246551
- Acronym / sponsor ID
- 2025-03523-01
- Conditions
- Otitis Media Acute, Otitis Media Effusion
- Keywords
- Otitis Media, Primary Health Care, Artificial Intelligence, Antimicrobial Stewardship, Clinical Decision Support Systems
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- Vastra Gotaland RegionOther government
- Collaborators
- Umeå University, Lund University, Linkoeping University, Göteborg University
- Study start
- 1 Dec 2025 (estimated)
- Primary completion
- 1 Dec 2027 (estimated)
- Study completion
- 31 Dec 2027 (estimated)
- First posted
- 24 Nov 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Acute otitis media (AOM), or middle ear infection, is one of the most common childhood infections and a leading cause of antibiotic prescribing in primary care. Diagnosing AOM can be challenging, as ear symptoms and eardrum appearances often overlap with mild or transient conditions. This uncertainty may lead to both unnecessary antibiotic use and missed cases requiring treatment, affecting patient safety and contributing to antibiotic resistance.
This study evaluates two digital tools designed to support more accurate diagnosis and treatment decisions in primary care:
- AOM Dx [diagnosis] Trainer (Otitspelet) - a gamified digital training program for physicians that provides interactive exercises using eardrum images and patient cases, with direct feedback to improve diagnostic accuracy and adherence to guidelines.
- AI-based diagnostic support - a system that analyses tympanic membrane images, with and without symptom and tympanometry data, to evaluate its potential for future diagnostic use.
The trial is coordinated by the Västra Götaland Region (VGR) in collaboration with Umeå University and conducted across four Swedish regions: Västra Götaland, Västerbotten, Östergötland, and Skåne. VGR leads the evaluation of the AOM Dx Trainer intervention, while Umeå University leads the AI development and retrospective diagnostic analyses. The study is carried out as a multicentre, cluster-randomised controlled trial in primary care, where participating primary care centres are randomised to either the training intervention or standard care.
Physicians are the research participants under evaluation. At intervention centres, physicians complete training with the AOM Diagnosis (Dx) Trainer before study start; at control centres, no training is provided. Each participating centre then conducts an 8-week observation period, during which physicians diagnose and manage patients with new-onset ear symptoms. Patients are included only to allow evaluation of physicians' diagnostic and treatment decisions and to provide data for AI analysis. Estimated patient enrollment is ~200. Depending on centre size and recruitment success, up to 20 primary care centres across four Swedish regions - Västra Götaland, Västerbotten, Östergötland, and Skåne - will participate. After each consultation, research nurses collect tympanic membrane images and tympanometry data from patients who have given informed consent. These data are used for expert panel reference diagnoses and retrospective AI analysis; no information is shared with treating physicians.
The primary outcome is diagnostic accuracy of tympanic membrane assessment by physicians trained with the AOM Dx Trainer compared with untrained physicians, using expert consensus as the reference standard. Secondary outcomes include adherence to treatment guidelines and antibiotic prescribing rates. The AI system's diagnostic performance will also be benchmarked against the expert panel and physician groups.
By combining educational and technological innovation, this study aims to enhance diagnostic precision, improve guideline adherence, and reduce unnecessary antibiotic use in primary care-strengthening antimicrobial stewardship and providing a scalable model for future infection management.
Detailed description
This multicentre, cluster-randomised controlled trial evaluates two digital innovations for improving diagnostic accuracy and treatment quality in acute otitis media (AOM) management in Swedish primary care: a gamified training tool for physicians (AOM Diagnosis [Dx] Trainer) and an AI-based diagnostic support system. The study assesses diagnostic accuracy, adherence to evidence-based treatment guidelines, and comparative AI performance.
The trial is coordinated by the Västra Götaland Region (VGR) in collaboration with Umeå University and conducted across four Swedish regions: Västra Götaland, Västerbotten, Östergötland, and Skåne. Up to 20 primary care centres will participate, depending on centre size and recruitment rates. Centres are randomised to either the AOM Dx Trainer intervention or standard care (control).
Study design and participants:
Both physicians and patients are research participants. Physicians in the intervention arm complete the AOM Dx Trainer before patient inclusion begins, while control physicians receive no training. Each centre recruits consecutive patients with new-onset ear symptoms (≤1 month) during an 8-week inclusion period (intervention or control). Consultations are conducted according to standard clinical practice. After each visit, research nurses ensure eligibility and consent and collect tympanic membrane images and tympanometry data solely for research purposes.
Interventions:
The AOM Dx Trainer is a gamified, case-based training tool designed to improve recognition of AOM and related conditions. Physicians classify anonymised tympanic images with symptom vignettes into diagnostic categories and receive immediate feedback. Training continues until a predefined performance threshold is reached.
The AI diagnostic tool, developed at Umeå University, uses convolutional neural networks (CNNs) to analyse tympanic images, with or without symptom and tympanometry data. AI analyses will be performed retrospectively in a laboratory setting and will not influence patient care.
Data collection:
After each visit, patients meet a research nurse who ensures eligibility and consent, and records demographics, symptom severity (AOM-SOS v5), and potential complicating factors (e.g., severe pain despite analgesics, immunosuppression, previous ear surgery, cochlear implant). The physician's diagnosis and any antibiotic prescription (drug and duration) are documented for later comparison with guideline recommendations and expert panel consensus. Physician characteristics are recorded under pseudonymised IDs. Tympanic membrane images are captured using CE-marked video otoscopes (EarPenguin) and tympanometry devices. All data are entered into case report forms (CRFs) and stored securely but are not shared with treating physicians, ensuring real-world diagnostic conditions.
Data handling and ethics:
All data are pseudonymised. Code keys are securely stored within each region. The national coordinating centre in Gothenburg oversees data management and quality assurance. Data are stored on GDPR-compliant servers. Ethical approval has been granted by the Swedish Ethical Review Authority (Ref. 2025-03523-01).
Expert panel reference diagnoses:
Tympanic images and tympanometry results are reviewed retrospectively by an expert panel (two ENT specialists and one senior GP). Consensus diagnoses serve as the reference standard for assessing diagnostic accuracy among physicians and for benchmarking AI performance.
Primary outcome:
Diagnostic accuracy of tympanic membrane classification (normal, AOM, erythematous membrane without effusion, or otitis media with effusion) compared with expert consensus.
Secondary outcomes:
Adherence to national treatment guidelines; antibiotic prescribing rates and duration; and comparative diagnostic performance between physicians and AI configurations.
Sample size and power:
The sample size calculation targets the primary research question. Using a bivariate logistic regression as a proxy (outcome: correct vs. incorrect diagnosis; predictor: intervention status), unpublished data from our group suggest approximately 50% diagnostic accuracy among physicians without AOM Dx Trainer training. We hypothesize an improvement to around 75% among trained physicians, which is considered a clinically relevant threshold. Assuming a two-sided alpha of 0.05 and 95% power, a minimum of 195 patients is required (G*Power 3.1.9.7). Therefore, approximately 200 patients will be recruited, with roughly equal numbers in the intervention and control arms. This target aligns with the planned multicentre cluster-randomised design and is feasible within the established Swedish primary care research network.
Study design
- Primary purpose
- Diagnosis
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| No Intervention: Standard Care - Control Group | Active comparator | Other: No Intervention - Standard CarePhysicians at control centres will provide standard care without access to the AOM Dx Trainer. Consultations will proceed as usual for patients with ear symptoms. Research nurses will collect tympanic membrane images and tympanometry data for expert panel and AI evaluation. |
| Behavioral: AOM Dx Trainer - Intervention Group | Experimental | Behavioral: AOM Dx Trainer (gamified educational program)Primary care physicians at centres randomized to the intervention arm will complete training with the AOM Diagnosis (Dx) Trainer, a gamified educational program designed to improve diagnostic accuracy in acute otitis media. After completing the training, these physicians will manage patients as usual. Research nurses will collect tympanic membrane images and tympanometry data for expert panel and AI evaluation. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (9 listed)
- Newly developed ear discomfort or symptoms within the past month. The patient seeks care at a participating primary care centre and is assessed by a physician because of these ear-related symptoms. Alternatively, for young children: respiratory tract infection with concurrent signs or symptoms suggesting possible ear involvement, even if the child cannot clearly express ear pain.
- Age: Children and adults of all ages are eligible to participate.
- Informed consent: The patient (or guardian for minors) agrees to participate and provides written informed consent. For children under 15 years, consent is obtained from both guardians before any data storage.
- The patient must have been managed by a physician who has consented to participate in the study (as a physician participant) and who is a GP specialist, GP resident, or junior physician (intern or basic training physician) working at the primary care centre.
- At intervention centres, the managing physician must have completed the AOM Diagnosis (Dx) Trainer and reached the required score threshold ("diploma") before including patients.
Key exclusion criteria (1 listed)
- Withdrawal of consent by the participant (physician or patient).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| AOM Dx Trainer (gamified educational program)Educational digital training program for physicians, not psychotherapy or counseling. Designed to improve diagnostic accuracy in acute otitis media through gamified learning with feedback. | Behavioural | Behavioral: AOM Dx Trainer - Intervention Group |
| No Intervention - Standard CareParticipants in this arm will receive standard care according to clinical routines, without access to the AOM Diagnosis (Dx) Trainer. No experimental or additional interventions will be applied. | Other | No Intervention: Standard Care - Control Group |
Primary outcome
Diagnostic accuracy of tympanic membrane assessment by primary care physicians
Time frame: During the 8-week inclusion period at each participating centre (per patient consultation).
Diagnostic accuracy of tympanic membrane classification (normal, acute otitis media, erythematous membrane without effusion, or otitis media with effusion) by primary care physicians trained with the AOM Dx Trainer compared with untrained physicians (control group). Accuracy is defined as correct versus incorrect diagnosis relative to the expert panel consensus. Analysed using mixed-effects logistic regression adjusted for physician sex, age, and training level (GP specialist, resident, or junior physician), with physician ID included as a random effect to account for clustering at the physician level.
2 secondary outcomes
Adherence to national AOM treatment guidelines
Time frame: During the 8-week inclusion period at each participating centre (per patient consultation).
Diagnostic performance across groups
Time frame: Retrospective analysis after completion of data collection (expected within 12 months of final patient inclusion).
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Nov 2025.
Related trials for Otitis Media Acute
Recruiting
Nasopharyngeal Carriage of S. Pneumoniae
Nasopharyngeal Carriage, Children, Only
Active, not recruiting
Dynamic Change and Immune Response to Nasopharyngeal Carriage and Acute Otitis Media Pathogens
Acute Otitis Media
RecruitingPhase 4
Comparative Effectiveness of Available Treatments for Sinus and Ear Infections in Children (Acute Otitis Media)
Acute Otitis Media (AOM)
Active, not recruitingObservational study
Evaluate Pathogens and Immunity to Acute Otitis Media in Healthy Children.
Nasopharyngeal Colonization and Acute Otitis Media
Not yet recruitingPhase 4
Amoxicillin-clavulanate Versus Amoxicillin Versus Placebo in Acute Otitis Media in Children
Acute Otitis Media, AOM - Acute Otitis Media
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
A study testing AOM Dx Trainer (gamified educational program) in people with Otitis Media Acute and Otitis Media Effusion, run by Vastra Gotaland Region.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 24 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Pär-Daniel Sundvall, Professor, MD, PhD (+46(0)72 250 61 96, par-daniel.sundvall@gu.se), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Diagnostic accuracy of tympanic membrane assessment by primary care physicians (time frame: During the 8-week inclusion period at each participating centre (per patient consultation).). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Nov 2025.